One case is reported of a patient with a pathogenic compound heterozygous NPHS2 variant (p.Arg138Gin + c.535-1G>T) who developed biopsy-proven FSGS recurrence ten years following transplantation (Table 3, patient 18) [35]. Here, NPHS2 is linked to focal segmental glomerulosclerosis.